Lee Pharma

Hyderabad, India Founded: 1997 • Age: 29 yrs Minicorn
Pharmaceutical company focused on providing APIs, intermediates, and finished dosage forms

About Lee Pharma

Lee Pharma is a Healthcare company based in Hyderabad (India) founded in 1997 by Venkata Reddy Alla. Pharmaceutical company focused on providing APIs, intermediates, and finished dosage forms. Lee Pharma has raised $7.04 million across 2 funding rounds from investors including MOEHS. The company has 1,381 employees. Lee Pharma was last valued at $12.93 million in June 2007. Its Indian entity Lee Pharma Limited reported revenue of β‚Ή929 Cr. Lee Pharma offers products and services including Active Pharmaceutical Ingredients, Intermediate Chemicals, Finished Formulations, and CDMO Services. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides. Its competitors include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals; 1 of its 3 listed competitors has raised funding.

Company details

Lee Pharma was established in 1997 in Hyderabad, India, within the pharmaceutical sector. Operations center on the production and supply of active pharmaceutical ingredients (APIs), key intermediates, and finished dosage forms. The company serves global markets through its manufacturing facilities, emphasizing compliance with regulatory standards for quality and safety in drug development and distribution. Leadership is provided by founder Venkata Reddy Alla as Managing Director.

  • Headquarters Hyderabad, India
  • Employees 1,381
  • Founders Venkata Reddy Alla
  • Stage Minicorn
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website leepharma.com
  • Social LinkedIn X Facebook
  • Legal Name Lee Pharma Limited
  • Date of Incorporation 06 Oct, 1997
  • Jurisdiction Hyderabad, Telangana, India
Key Metrics
  • Annual Revenue
    ₹929 Cr

    FY 2025 · +3% YoY

  • Net Profit
    ₹35.52 Cr

    FY 2025 · 4% margin

  • EBITDA
    ₹123 Cr

    FY 2025 · 13% margin

  • Total Equity Funding
    $7.04M (USD)

    in 2 rounds

  • Latest Funding Round
    $1.38M (USD), Series A

    Mar 2024

  • Investors
  • Employee Count
    1,381

Products & Services of Lee Pharma

Lee Pharma offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients, Intermediate Chemicals, Finished Formulations, and CDMO Services.

Active Pharmaceutical Ingredients
Raw Materials

High-quality APIs for drug manufacturing and global supply.

Intermediate Chemicals
Chemical Components

Essential intermediates used in pharmaceutical production processes.

Finished Formulations
Medicines

Ready-to-use formulations for various therapeutic applications.

CDMO Services
Contract Manufacturing

Custom development and manufacturing services for pharmaceuticals.

Funding Insights of Lee Pharma

Lee Pharma has successfully raised a total of $7.04M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $1.38 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $7.04M
  • Total Rounds 2
  • Last Round Series A β€” $1.38M
  • First Round $5.66M

    (Jun 2007)

  • Investors Count 1

All 2 funding rounds of Lee Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2024$1.38MSeries A––
–
Jun 2007$5.66MSeries A$12.93MMOEHS
–
Valuation history
DateValuationStage
Jun 2007$12.93Mβ€’β€’β€’β€’β€’β€’β€’β€’

Last known valuation $12.93M (Jun 2007). 1 investors in total: 1 institutional.

Investors in Lee Pharma

Lee Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include MOEHS.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Produces high-quality chemicals for the pharmaceutical industry.
1962moehs.comRubi, Spain
Premium access

Investor details for Lee Pharma

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Lee Pharma Limited (Lee Pharma)

Lee Pharma Limited is the primary company behind Lee Pharma. The board of Lee Pharma Limited currently have 8 directors; the longest-serving is Venkata Reddy Alla, appointed in 1997. 5 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Venkata Reddy Alla
DIN 00018534
Managing Director06 Oct 199729 yrsLee Pharma Limited
Dr Gopala Rao Tatineni
DIN 00043939
Director22 Apr 199927 yrs 6 moLee Pharma Limited
Raghumitra Alla
DIN 00080789
Whole-time director04 May 200620 yrs 6 moLee Pharma Limited
Alla Ratna Kumari
DIN 00022478
Whole-time director27 Aug 200719 yrs 2 moLee Pharma Limited
Vijaykumar Raghunandanprasad Agrawal
DIN 01710632
Director27 Sep 200719 yrs 1 moLee Pharma Limited
Santosh Babu Busani
DIN 09097558
Director30 Sep 20215 yrs 1 moLee Pharma Limited
Anil Jain
DIN 00181960
Nominee Director29 Jul 20233 yrs 3 moLee Pharma Limited
Ramaseshappa Siva Prasad Panchangam
DIN 09447160
Director30 Sep 20242 yrs 1 moLee Pharma Limited

People of Lee Pharma

1 people are tracked at Lee Pharma (1 in leadership); the tracked headcount is 1,381.

NameRoleGroup
Founder & Managing DirectorLeadership
Premium access

Complete people profiles for Lee Pharma

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Lee Pharma

Figures of Lee Pharma Limited, the primary company behind Lee Pharma, for FY 2025. Revenue was ₹929 Cr (+3% year on year). Net profit was ₹35.52 Cr (4% margin). EBITDA was ₹123 Cr (13% margin). Revenue has grown at a compounded annual rate of +13% over three years and +23% over five years.

  • ₹929 CrRevenue · FY 2025 · +3% YoY
  • ₹35.52 CrNet profit · 4% margin
  • ₹123 CrEBITDA · 13% margin
  • ₹1.64 CrPaid-up capital
  • 1,381Employees (provident fund records)
  • +13%Revenue CAGR, 3 years
  • +23%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Lee Pharma Limited are on its company page.

Premium access

Detailed financial statements for Lee Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Lee Pharma

4 dated milestones of Lee Pharma across 27 years, from founding to its latest funding, stage changes and deals.

  1. Founded Lee Pharma is founded.
  2. Funding First funding round of $5.7M.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Series A, of $1.4M.

Competitors of Lee Pharma

Lee Pharma has 3 listed competitors in our database, 1 of them funded. They include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
indoco.com1947Mumbai, India6,291
APIs manufacturing and formulation services are provided in therapeutic segments.
concordbiotech.com2000Ahmedabad, India1,598
APIs and enzymes are manufactured through fermentation by the CDMO.
bdrpharma.com2003Mumbai, India$88.16M1,864
APIs and finished products are developed and manufactured.
Premium access

Detailed competitors of Lee Pharma

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Lee Pharma

The website of Lee Pharma (leepharma.com) receives about 3.3K visits a month and ranks #1,522,364 among all websites worldwide, #2,011 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    3.3K

    ▼ 57.3% vs previous month

  • Unique visitors
    4K

    per month

  • Global rank
    #1,522,364

    among all websites

  • Category rank
    #2,011

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Lee Pharma. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
leespharm.com
100%
#12,343,912View details
leo-pharma.us
leo-pharma.us
100%
#5,900,667–
trispharma.com
99%
9.7K#2,135,145View details
global-pharma.com
62%
3.2K#6,537,990View details
ecanpharma.com
ecanpharma.com
61%
–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 6 similar websites and full traffic analytics for Lee Pharma

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 6 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Lee Pharma (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M1,820
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M12,470
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M4,260
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Lee Pharma

Premium access

Complete news archive for Lee Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lee Pharma

Lee Pharma was founded in 1997 and raised its 1st funding round 10 years after it was founded.

Lee Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Lee Pharma is a funded company, having raised a total of $7.04M across 2 funding rounds to date. The company's 1st funding round was a Series A of $5.66M, raised on Jun 2007.

Lee Pharma has 1,381 employees.

The primary company behind Lee Pharma, Lee Pharma Limited, reported revenue of β‚Ή929 Cr for FY 2025, up 3% year on year.

Lee Pharma was established in 1997 in Hyderabad, India, within the pharmaceutical sector. Operations center on the production and supply of active pharmaceutical ingredients (APIs), key intermediates, and finished dosage forms. The company serves global markets through its manufacturing facilities, emphasizing compliance with regulatory standards for quality and safety in drug development and distribution. Leadership is provided by founder Venkata Reddy Alla as Managing Director.

Lee Pharma's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Indoco Remedies.

Lee Pharma offers Active Pharmaceutical Ingredients, Intermediate Chemicals, Finished Formulations, and CDMO Services.

Lee Pharma has 1 investor. Key investors include MOEHS.

The valuation of Lee Pharma is $12.93M as of Jun 2007.

Lee Pharma operates through Lee Pharma Limited.

The legal entities of Lee Pharma currently have 8 directors, including Alla Ratna Kumari, Venkata Reddy Alla, Santosh Babu Busani and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available